The Sliding-Filament Mechanism

A sarcomere is the repeating contractile unit of striated muscle, bounded by two Z-discs and containing an ordered array of two filament types. Thick filaments, built from hundreds of myosin molecules, occupy the center of the sarcomere and constitute the A band — the region visible as a dark band under polarized light because of its high protein density and birefringence. Thin filaments, built from actin monomers polymerized into a double helix along with the regulatory proteins tropomyosin and troponin, are anchored at the Z-discs and project inward, interdigitating with the thick filaments. The region containing only thin filaments, on either side of the Z-disc, is the I band; the central region of the A band where thick filaments have no overlapping thin filaments is the H zone. The sliding-filament mechanism states that during contraction, thin filaments are drawn further into the A band, increasing the region of overlap between thick and thin filaments. Critically, the length of the thick filaments (about 1.6 μm in vertebrate skeletal muscle) and the length of the thin filaments (about 1.0 μm) do not change. What changes is the width of the I band, which narrows as thin filaments slide inward, and the width of the H zone, which narrows or disappears as thin filaments from opposite sides approach or overlap each other in the middle. Meanwhile the width of the A band — set by the fixed length of the thick filament — remains constant throughout shortening. This single observation, that the A band does not narrow while the I band and sarcomere as a whole do, is the empirical signature of sliding rather than filament contraction. Shortening at the whole-muscle level is simply the additive consequence of this sliding, multiplied across thousands of sarcomeres arranged end to end in series within each myofibril, and across bundles of myofibrils arranged in parallel within each fiber. A sarcomere at rest in mammalian skeletal muscle is roughly 2.0–2.2 μm long; during a strong contraction it can shorten to perhaps 1.6–1.8 μm, and it can be stretched passively well beyond 3.0–3.6 μm before thick and thin filaments lose all overlap and can no longer interact. This length range is the physical basis of the Muscle Mechanics: Length-Tension & Force-Velocity relationship, where the amount of force a muscle can generate depends directly on how much filament overlap — and therefore how many potential cross-bridge sites — exist at a given sarcomere length.

Step 1 — the resting architecture. In a relaxed sarcomere, thick filaments sit centered between two Z-discs, symmetric about the M-line. Thin filaments extend from each Z-disc toward the center but, at typical resting lengths, do not meet in the middle — leaving a central H zone. Each thick filament is surrounded hexagonally by six thin filaments in the region of overlap, and each thin filament by three thick filaments, giving the characteristic double-hexagonal lattice seen in electron-microscope cross sections.

Step 2 — cross-bridge formation and the power stroke. Contraction begins when calcium released from the sarcoplasmic reticulum binds troponin, causing tropomyosin to shift and expose myosin-binding sites on actin. Myosin heads projecting from the thick filament, already energized by ATP hydrolysis into a high-energy conformation, bind actin to form a cross-bridge. Release of inorganic phosphate triggers the power stroke, a conformational rotation of the myosin head that pulls the attached thin filament roughly 10 nanometers toward the center of the sarcomere (the exact detailed chemistry of this cycle — ATP binding, hydrolysis, phosphate release, ADP release — belongs properly to the Cross-Bridge Cycle, and is only sketched here to explain where the pulling force comes from).

Step 3 — sliding, not shortening. Because each myosin head acts like an oar pulling on a fixed-length actin filament, repeated, asynchronous cycles of attachment, power stroke, and detachment by many heads along the thick filament ratchet the thin filament progressively deeper into the A band. The thick filament does not elongate or compress; it is a rigid bipolar bundle of myosin tails with heads projecting outward in opposite directions from its two halves, so that it pulls thin filaments inward from both Z-discs simultaneously. The thin filament likewise does not stretch or coil; its actin backbone is a comparatively stiff helical polymer that simply translates in space.

Step 4 — the geometric consequence for the banding pattern. As sliding proceeds, three measurable things happen, all consistent with rigid filaments changing overlap rather than length:

Step 5 — summation across the fiber. A single sarcomere shortens by only a fraction of a micron per twitch, but a human sartorius myofibril contains on the order of tens of thousands of sarcomeres in series along its length, so millions of small individual slidings sum to whole-muscle shortening of several centimeters. Because sarcomeres are also arranged in parallel across the fiber's cross-sectional area, this parallel arrangement determines the force a muscle can generate, while the series arrangement determines how far and how fast it can shorten — the anatomical basis of the fiber-architecture principles built on top of the sliding-filament mechanism.

The sliding-filament mechanism was established in 1954 by two independent teams publishing back-to-back in Nature: Andrew Huxley and Rolf Niedergerke, using interference microscopy on living, intact frog muscle fibers, and Hugh Huxley and Jean Hanson, using phase-contrast and electron microscopy on isolated myofibrils. The two Huxleys were unrelated, and the coincidence of name and near-simultaneous discovery is one of the more remarkable stories in physiology. Hugh Huxley and Jean Hanson dissected single myofibrils and measured the width of the A band, I band, and H zone directly under the light microscope as the myofibrils shortened, either actively or by passive stretch. They found that the A band length stayed essentially constant across a wide range of total sarcomere lengths, while the I band and H zone changed length in direct proportion to changes in overall sarcomere length. This is precisely the prediction of sliding: if filaments themselves changed length, the A band should shrink or grow with contraction; instead, only the region between the ends of overlapping filaments changed. They also used electron microscopy to confirm the physical existence of two structurally distinct filament systems — thick and thin — arranged in the hexagonal lattice, rather than a single continuous contractile fibril as earlier theories (based on a uniform contractile protein called "myosin B" thought to shorten uniformly) had assumed. Andrew Huxley and Rolf Niedergerke, working independently at Cambridge, used a home-built interference microscope sensitive enough to resolve the banding pattern in living, intact single fibers of frog muscle without fixation or staining — critical because it let them watch the same fiber shorten in real time rather than compare fixed snapshots at different lengths. They confirmed the same result: constant A-band width, variable I-band width, with the arithmetic relationship between the two matching the geometric prediction that thin filaments were sliding a measurable distance into the A band with no change in thick-filament length. A second, independent line of evidence came a few years later from X-ray diffraction studies (notably by Hugh Huxley and collaborators), which measure the periodic spacing of protein subunits in filaments still arranged in their native lattice within intact, resting or contracting muscle. X-ray diffraction showed that the axial repeat distance of both the myosin and actin arrays stayed constant across the full physiological range of sarcomere lengths, directly ruling out any folding, coiling, or intrinsic shortening of the protein filaments themselves — the actin and myosin molecular lattices were rigid and unchanging in periodicity; only their relative position shifted. The definitive quantitative test came from Andrew Huxley's later work with fellow physiologist A. M. Gordon and F. J. Julian (1966), who plotted isometric tension as a function of sarcomere length in single frog muscle fibers under a technique that used a servo-controlled system (the "spot-follower") to hold sarcomere length constant despite compliance in the tendons and attachments. Their length-tension curve showed a plateau of maximal tension over the sarcomere-length range where filament overlap geometry (measured independently by electron microscopy) predicted a maximal, constant number of potential myosin cross-bridge sites, and a linear fall in tension on either side of the plateau matching, almost point for point, the predicted loss of overlap as filaments were stretched apart or as thin filaments began to overlap each other and interfere on the shortening side. This close, quantitative match between predicted geometric overlap and measured force is considered the strongest single piece of evidence that force generation depends directly on the number of overlapping cross-bridge sites — the mechanical fingerprint of the sliding-filament model, and the direct experimental foundation of Muscle Mechanics: Length-Tension & Force-Velocity.

Example 1 — relating sarcomere shortening to whole-muscle shortening. Suppose a human muscle fiber is 6 cm long and, at rest, its sarcomeres average 2.4 μm in length (slightly above the optimal ~2.0–2.2 μm, as is common in a passively stretched muscle in situ). During a maximal contraction the muscle shortens so that each sarcomere contracts to 2.0 μm. Step 1: Number of sarcomeres in series.

Step 2: Shortening per sarcomere.

Step 3: Total shortening of the fiber.

So a fiber shortening its sarcomeres by less than half a micron each nonetheless shortens by a full centimeter — about 17% of its resting length — purely because that small change is repeated across 25,000 units in series. This illustrates why series summation, not any dramatic per-sarcomere event, explains gross muscle excursion; the underlying molecular event (cross-bridges pulling thin filaments a few nanometers per stroke, repeated many times per sarcomere) is the same event described in the Cross-Bridge Cycle.

Example 2 — predicting relative tension from filament overlap geometry. Using the standard frog-muscle filament dimensions established by electron microscopy (thick filament 1.6 μm, bare zone in its center 0.2 μm with no myosin heads, thin filament 1.0 μm on each side of the Z-disc), predict whether an isolated fiber held at a sarcomere length of 3.65 μm can generate active tension. Step 1: Determine the maximum possible span of interaction. Thick filament half-length is 0.8 μm from the M-line; thin filament reaches 1.0 μm from the Z-disc. For any overlap to exist between a thin filament and the myosin heads on the thick filament, the distance from Z-disc to the nearest myosin head (thick filament half-length minus bare zone half-width, i.e., 0.8 − 0.1 = 0.7 μm from M-line, or equivalently thin filament must reach in to that point) must be compared against half the sarcomere length. Step 2: Half-sarcomere length at 3.65 μm total is 1.825 μm. Step 3: The thin filament (1.0 μm) plus the thick filament half-length (0.8 μm) sum to 1.8 μm — this is the classic value, established experimentally by Gordon, Huxley and Julian, at which overlap between thick and thin filaments just disappears entirely (myofilament tip-to-tip). Step 4: Since the half-sarcomere length (1.825 μm) slightly exceeds 1.8 μm, there is no overlap between thick and thin filaments at all — no myosin heads can reach an actin site, and the fiber should generate zero active tension, even though it is fully excitable and its calcium-release machinery works normally. This matches the experimentally measured length-tension curve almost exactly: tension falls to zero near a sarcomere length of about 3.6–3.65 μm in frog muscle, precisely because filament overlap — not any failure of excitation-contraction coupling — has run out. This is the clearest possible demonstration that active force depends on filament geometry, the geometric consequence of the sliding-filament model, rather than on some independent property of "activation strength."

Hugh Esmor Huxley trained originally in physics at Cambridge before turning to biological ultrastructure, and he pioneered the use of both electron microscopy and X-ray diffraction on muscle — an unusually powerful combination, since electron microscopy revealed static structure at high resolution while X-ray diffraction, applied to living or intact muscle, could report on the arrangement of protein subunits without the risk of fixation artifacts. Working with the physiologist Jean Hanson, he built the direct light-microscope case for sliding filaments in 1954, and he spent the following decades refining the model with X-ray diffraction, establishing the cross-bridge tilting mechanism that generates the sliding force. Andrew Fielding Huxley, unrelated despite the shared surname, was a physiologist whose earlier landmark work with Alan Hodgkin on the Action Potential Mechanism and the squid giant axon had already earned him a central place in nerve physiology before he turned, together with Rolf Niedergerke, to the mechanical problem of muscle shortening — bringing with him a rigorous quantitative, model-building style that led directly to the 1966 Gordon-Huxley-Julian length-tension experiments.

Rigor mortis is a direct clinical demonstration of the sliding-filament apparatus locked in place: after death, ATP synthesis stops, and myosin heads that have bound actin cannot detach (detachment normally requires fresh ATP binding), so cross-bridges freeze in the attached state and the whole muscle becomes rigid — a phenomenon forensic pathologists use to help estimate time since death.

Cardiac and skeletal myopathies frequently trace back to mutations in the thick- or thin-filament proteins themselves — for example mutations in the beta-myosin heavy chain or in troponin genes causing hypertension-independent hypertrophic cardiomyopathy — precisely because any structural defect in the filaments that carry out sliding compromises the whole contractile cycle; understanding normal sliding geometry is the baseline against which these pathologies are interpreted.

Statin-associated myopathy and other drug-induced muscle disorders are evaluated in part by assessing sarcomere structural integrity, since disruption of the ordered A-band/I-band lattice (visible on muscle biopsy) is a hallmark of toxic or metabolic myopathies, distinguishing them from purely neurogenic muscle weakness.

Sports science and rehabilitation use the length-tension relationship derived from sliding-filament geometry to design stretching and strengthening protocols: an overstretched muscle (sarcomeres pulled toward the descending limb of overlap) generates less active force, informing decisions about optimal joint angles for strength training and about how immobilization at shortened or lengthened positions alters sarcomere number over time.

Biotechnology and drug development exploit direct pharmacological modulation of the sliding mechanism: the drug omecamtiv mecarbil, developed for heart failure, works by directly slowing the release step of the myosin cross-bridge cycle, prolonging the attached, force-generating state and increasing the fraction of time cross-bridges spend actively pulling thin filaments — a rational drug design made possible only because the geometric and kinetic details of sliding and cross-bridge cycling are precisely known.

Ask the tutor: How exactly does ATP binding cause a myosin head to detach from actin, and why does the absence of ATP cause rigor rather than relaxation?